The effect of the family-centered educational program on medication management and quality of life in elderly patients with ischemic heart disease.

Phase 3

• Conditions: Ischemic Heart Disease.; Chronic ischemic heart disease, unspecified

• Registration Number: IRCT20180513039646N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 October 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 84

Inclusion Criteria

Reading and writing literacy (for patient or family member)
Age between 60 and 75 years
The absence of diagnosed psychological illness
Ischemic Heart Disease Detected by Heart Disease
At least 6 months have passed since the diagnosis of the disease and has a sustained pain and hemodynamic status
A positive response to two or more questions is the HbL Drug Dangers Questionnaire that is used to assess the problems associated with drug use in the elderly.
Residence of an active member of the family at or near the patient's place of residence

Exclusion Criteria

Entry into the acute phase of the disease
The company participated simultaneously in other similar specialized studies
Having even a session absent in the classroom for a patient or family member
Unwillingness (patient and active member of the family) to continue participating in the study or death of a sick person or an active member of the family
Do not answer phone at least for two times

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life: It is the individual's thoughts of his or her living conditions, according to the culture and value system in which they live, and the relation of these receipts to their goals, expectations, expectations, standards and priorities. Pharmaceutical Management: Includes patient-focused care that optimizes safe, effective, and effective drug treatment, and is provided through collaboration with patients and their care team. Timepoint: These variables are measured at the beginning of the study and three months after the intervention. Method of measurement: The quality of life in this study is a score that a person earns based on the LEIPAD Quality of Life Questionnaire.